Parisi Gray Wealth Management Has $3.47 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Parisi Gray Wealth Management grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,591 shares of the healthcare conglomerate’s stock after buying an additional 24 shares during the period. UnitedHealth Group makes up 1.4% of Parisi Gray Wealth Management’s portfolio, making the stock its 17th largest position. Parisi Gray Wealth Management’s holdings in UnitedHealth Group were worth $3,470,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $26,000. Robbins Farley bought a new position in UnitedHealth Group in the 3rd quarter valued at about $25,000. CGC Financial Services LLC boosted its position in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new stake in shares of UnitedHealth Group during the first quarter worth $35,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Down 0.3 %

UnitedHealth Group stock traded down $1.27 during trading hours on Thursday, hitting $491.83. The stock had a trading volume of 311,961 shares, compared to its average volume of 4,038,452. The stock’s 50-day moving average price is $503.73 and its 200-day moving average price is $518.79. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $554.70. The stock has a market capitalization of $453.43 billion, a P/E ratio of 20.68, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same period in the prior year, the business posted $5.34 earnings per share. The company’s revenue was up 14.1% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 31.54%.

Analyst Ratings Changes

Several research firms recently issued reports on UNH. Piper Sandler dropped their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. HSBC reissued a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Truist Financial restated a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Thursday, November 30th. Finally, Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $579.33.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.